Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Carducci · SciRah

Researcher profile · Semantic Scholar

M. Carducci

Share profile

M. Carducci — researcher profile on SciRah

h-index: 98
Works: 738
Citations: 51K

Most-cited papers

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
R. Phillips, William Y. Shi, M. Deek, N. Radwan +22 more
2020JAMA Oncology1,049 citations Open access
Semantic Scholar
Nivolumab Versus Everolimus in Patients With Advanced Renal Cell Carcinoma: Updated Results With Long-Term Follow-up of the Randomized, Open-Label, Phase 3 CheckMate 025 Trial
R. Motzer, B. Escudier, S. George, H. Hammers +27 more
2020Cancer292 citations Open access
Semantic Scholar
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.
S. Denmeade, Hao Wang, N. Agarwal, David C. Smith +24 more
2021Journal of Clinical Oncology116 citations Open access
Semantic Scholar
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
M. Deek, K. Van der Eecken, R. Phillips, N. Parikh +20 more
2021European Urology93 citations Open access
Semantic Scholar
LBA67 Phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients (Pts) with renal cell carcinoma (RCC) undergoing nephrectomy (PROSPER, ECOG-ACRIN EA8143), a National Clinical Trials Network trial
M. Allaf, S. E. Kim, L. Harshman, D. F. McDermott +16 more
2022Annals of Oncology85 citations Open access
Semantic Scholar
Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
C. Friedman, Alexandra Snyder Charen, Qin C. Zhou, M. Carducci +11 more
2020Journal for ImmunoTherapy of Cancer77 citations Open access
Semantic Scholar
Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC).
H. Hammers, Dendra Vonmerveldt, C. Ahn, R. Nadal +8 more
202073 citations
Semantic Scholar
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
A. Correa, Opeyemi A. Jegede, N. Haas, K. Flaherty +11 more
2021European Urology71 citations Open access
Semantic Scholar
Transcriptional profiling of primary prostate tumor in metastatic hormone sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial
A. Hamid, H.-C. Huang, V. Wang, Y.-H. Chen +12 more
2021Annals of Oncology69 citations Open access
Semantic Scholar
Nivolumab plus Ipilimumab, with or without Enzalutamide, in AR-V7-expressing Metastatic Castration-Resistant Prostate Cancer: A Phase-2 Nonrandomized Clinical Trial
E. Shenderov, K. Boudadi, W. Fu, Hao Wang +13 more
2021The Prostate68 citations Open access
Semantic Scholar
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer.
J. Hearn, C. Sweeney, N. Almassi, Chad A. Reichard +10 more
2020JAMA Oncology66 citations Open access
Semantic Scholar
Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non–muscle-invasive Bladder Cancer (BRIDGE)
M. Kates, X. Chu, N. Hahn, E. Pietzak +10 more
2023European Urology Focus51 citations Open access
Semantic Scholar
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial
M. Markowski, M. Taplin, Rahul R. Aggarwal, L. Sena +16 more
2024Nature Communications48 citations Open access
Semantic Scholar
Supraphysiological testosterone induces ferroptosis and activates immune pathways through nucleophagy in prostate cancer
Raj Kumar, Janet Mendonca, Olutosin Owoyemi, K. Boyapati +21 more
2021Cancer Research43 citations Open access
Semantic Scholar
Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy
Laura A. Sena, Hao Wang, Su J. Lim Scm, Irina Rifkind +11 more
2020European Journal of Cancer41 citations Open access
Semantic Scholar
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy
T. Choueiri, H. Kluger, S. George, S. Tykodi +16 more
2022Journal for ImmunoTherapy of Cancer38 citations Open access
Semantic Scholar
Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial
A. Bryce, Yu-Hui Chen, Glenn Liu, M. Carducci +10 more
2020European Urology Oncology37 citations Open access
Semantic Scholar
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
P. Tran, Kathryn Lowe, Hua-Ling Tsai, D. Song +27 more
2022Journal of Clinical Oncology35 citations Open access
Semantic Scholar
Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA
N. Matsubara, J. de Bono, D. Olmos, G. Procopio +17 more
2022Clinical Cancer Research35 citations Open access
Semantic Scholar
Patterns of recurrence and modes of progression after metastasis-directed therapy in oligometastatic castration-sensitive prostate cancer
M. Deek, K. Taparra, D. Dao, L. Chan +17 more
2020International Journal of Radiation Oncology, Biology, Physics31 citations Open access
Semantic Scholar
Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer.
Nicole Senft, L. Hamel, Mark A. Manning, Seongho Kim +9 more
2020JAMA Oncology30 citations Open access
Semantic Scholar
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)
H. Hasan, M. Deek, R. Phillips, R. Hobbs +27 more
2020BMC Cancer27 citations Open access
Semantic Scholar
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
S. Halabi, A. Roy, L. Rydzewska, Si-Yuan Guo +16 more
2024Journal of Clinical Oncology26 citations Open access
Semantic Scholar
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
S. Halabi, Qian-yu Yang, Akash Roy, B. Luo +16 more
2023Journal of Clinical Oncology26 citations Open access
Semantic Scholar
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics
P. Sutera, K. Van der Eecken, A. Kishan, A. Hamid +18 more
2022Prostate Cancer and Prostatic Diseases24 citations Open access
Semantic Scholar
FRACTION-RCC: Innovative, high-throughput assessment of nivolumab + ipilimumab for treatment-refractory advanced renal cell carcinoma (aRCC).
T. Choueiri, H. Kluger, S. George, S. Tykodi +14 more
202024 citations
Semantic Scholar
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial.
C. Marshall, Benjamin A. Teply, Jia-Yun Lu, L. Oliveira +14 more
2024JAMA Oncology22 citations Open access
Semantic Scholar
Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound study
G. Roubaud, M. Özgüroğlu, N. Penel, N. Matsubara +19 more
2022European Journal of Cancer21 citations Open access
Semantic Scholar
Changes in the Place of Death for Older Adults with Cancer: Reason to Celebrate or a Risk for Unintended Disparities?
Ramy Sedhom, Pei-lun Kuo, Arjun Gupta, Thomas J. Smith +3 more
2020Journal of Geriatric Oncology21 citations Open access
Semantic Scholar
Luminal B subtype as a predictive biomarker of docetaxel benefit for newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A correlative study of E3805 CHAARTED.
A. Hamid, X. V. Wang, Yu-Hui Chen, Felix Y. Feng +11 more
202020 citations
Semantic Scholar
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy.
P. Grivas, V. Koshkin, X. Chu, S. Cole +10 more
2023European Urology Oncology19 citations
Semantic Scholar
Effects of Behavioral Weight Loss and Metformin on Insulin-like Growth Factors in Cancer Survivors: A Randomized Trial.
Hsin-Chieh Yeh, Nisa M. Maruthur, Nae-Yuh Wang, G. Jerome +13 more
2021Journal of Clinical Endocrinology and Metabolism18 citations Open access
Semantic Scholar
Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer
Yuki Yoshikawa, Konrad H. Stopsack, X. V. Wang, Yu-Hui Chen +14 more
2022Molecular Oncology17 citations Open access
Semantic Scholar
PrE0807: A phase Ib feasibility trial of neoadjuvant nivolumab (N) without or with lirilumab (L) in cisplatin-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC).
P. Grivas, Jun Yin, V. Koshkin, S. Cole +9 more
202117 citations
Semantic Scholar
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)
M. Morris, J. M. Mota, K. Lacuna, P. Hilden +9 more
2021European Urology Oncology17 citations Open access
Semantic Scholar
Role of bromodomain and extraterminal (BET) proteins in prostate cancer
Adel Mandl, M. Markowski, M. Carducci, E. Antonarakis
2023Expert Opinion on Investigational Drugs16 citations
Semantic Scholar
Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study
S. Eggly, Nicole Senft, Seongho Kim, E. Heath +9 more
2022Cancer Medicine16 citations Open access
Semantic Scholar
Olaparib efficacy in patients with metastatic castration-resistant prostate cancer (mCRPC) carrying circulating tumor (ct) DNA alterations in BRCA1, BRCA2 or ATM: Results from the PROfound study.
N. Matsubara, J. de Bono, D. Olmos, G. Procopio +16 more
202116 citations
Semantic Scholar
High-dose administration of tyrosine kinase inhibitors to improve clinical benefit: A systematic review.
S. Gerritse, Jorien B. E. Janssen, M. Labots, R. de Vries +4 more
2021Cancer Treatment Reviews16 citations Open access
Semantic Scholar
Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?
M. Hussain, M. Carducci, N. Clarke, Sarah E. Fenton +10 more
2022Journal of Clinical Oncology15 citations Open access
Semantic Scholar
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399
R. Gentzler, Liza C. Villaruz, J. Rhee, B. Horton +10 more
2023The Oncologist14 citations Open access
Semantic Scholar
Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
R. Aggarwal, A. Starodub, Brian D. Koh, G. Xing +2 more
2022Clinical Cancer Research14 citations Open access
Semantic Scholar
Physicians’ use of plain language during discussions of prostate cancer clinical trials with patients
Luke Thominet, L. Hamel, Fatmeh Baidoun, T. F. Moore +5 more
2022Patient Education and Counseling14 citations Open access
Semantic Scholar
CAPItello-280: A phase III study of capivasertib and docetaxel versus placebo and docetaxel in metastatic castration-resistant prostate cancer.
S. Crabb, D. Ye, H. Uemura, T. Morris +5 more
2023Journal of Clinical Oncology13 citations
Semantic Scholar
The ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patients
K. Visvanathan, Dana Petry, Michelle S. McCullough, B. May +16 more
2023Journal of cancer survivorship13 citations
Semantic Scholar
The international penile advanced cancer trial (InPACT): The first phase III trial for squamous carcinoma of the penis with regional lymph node metastases.
C. Pettaway, S. Nicholson, P. Spiess, L. Pagliaro +13 more
2022Journal of Clinical Oncology12 citations
Semantic Scholar
ARC-6: A phase 1b/2, open-label, randomized platform study to evaluate efficacy and safety of etrumadenant (AB928)-based treatment combinations in patients with metastatic castrate-resistant prostate cancer (mCRPC).
S. Subudhi, J. Bendell, M. Carducci, Lisa M. Kopp +4 more
202112 citations
Semantic Scholar
ORCHID: A phase II study of Olaparib in Metastatic Renal Cell Carcinoma Patients HarborIng a BAP1 or Other DNA Repair Gene Mutations
Georges Ged, Irina Rifkind, Lori Tony, Keegan Daugherty +4 more
2023The Oncologist11 citations Open access
Semantic Scholar
Eight-year survival rates by baseline prognostic groups in patients with metastatic hormone-sensitive prostate cancer (mHSPC): An analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.
Abhishek Tripathi, Yu-Hui Chen, D. Jarrard, N. Hahn +14 more
2022Journal of Clinical Oncology11 citations
Semantic Scholar
First-in-human phase 1 study of CC-94676, a first-in-class androgen receptor (AR) ligand-directed degrader (LDD), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
D. Rathkopf, M. Patel, A. Choudhury, D. Rasco +16 more
2024Journal of Clinical Oncology10 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Antonarakis×13
Invite
E. Antonarakis — researcher profile on SciRah
C. Paller×11
Invite
C. Paller — researcher profile on SciRah
M. Eisenberger×11
Invite
M. Eisenberger — researcher profile on SciRah
M. Markowski×10
Invite
M. Markowski — researcher profile on SciRah

×9

Invite

S. Denmeade — researcher profile on SciRah

Invite

M. Deek — researcher profile on SciRah

Invite

K. Pienta — researcher profile on SciRah

Invite

P. Tran — researcher profile on SciRah

Invite

G. Procopio — researcher profile on SciRah

Invite

R. Phillips — researcher profile on SciRah

Invite

C. Deville — researcher profile on SciRah

Invite

S. Greco — researcher profile on SciRah